Tokai Pharmaceuticals CEO Gregory Flesher's 2019 pay slips 11% to $843K
Tokai Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: March 31, 2020
Tokai Pharmaceuticals reported fiscal year 2019 executive compensation information on March 31, 2020.
In 2019, three executives at Tokai Pharmaceuticals received on average a compensation package of $611K, a 8% decrease compared to previous year.
Average pay of disclosed executives at Tokai Pharmaceuticals
Gregory J. Flesher, Chief Executive Officer, received $843K in total, which decreased by 11% compared to 2018. 57% of Flesher's compensation, or $480K, was in salary. Flesher also received $294K in option awards, $67K in stock awards, as well as $1.7K in other compensation.
Catherine C. Turkel, President, received a compensation package of $598K, which decreased by 4% compared to previous year. 62% of the compensation package, or $368K, was in salary.
Jon S. Kuwahara, Senior Vice President of Finance and Administration, earned $391K in 2019, a 9% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on March 31, 2020.